Recombinant Variola virus B3R Protein ，His & Myc

B3R, or B-Cell and Blood Differentiation Factor 3 Receptor, is a protein that has garnered attention in the field of immunology and therapeutic development due to its significant role in B-cell maturation and antibody production. Research on B3R has expanded in recent years, as it plays a critical role in the immune response, particularly in the differentiation of B-cells into plasma cells that produce antibodies against pathogens. The understanding of B3R signaling pathways can provide insights into various diseases, including autoimmune disorders, where B-cell functionality is often dysregulated. Moreover, the implications of B3R in vaccine development are noteworthy, as enhancing B-cell responses could lead to more effective immunizations. Recent studies focus on the structural and functional characterization of B3R, seeking to unravel its mechanism of action at the molecular level. These advancements may pave the way for novel therapeutic strategies targeting B3R, aiming to modulate immune responses in a controlled manner, thus improving treatment options for conditions linked to B-cell abnormalities. As research progresses, B3R's potential as a biomarker for immune system health is also being explored, highlighting its significance in both basic and applied immunological research.